Y Miura Selected Research

Y Miura Research Topics

Disease

22	Neoplasms (Cancer) 12/2022 - 01/2000
8	Graft vs Host Disease (Graft-Versus-Host Disease) 02/2008 - 07/2000
7	Hepatocellular Carcinoma (Hepatoma) 07/2001 - 04/2000
6	Ascites 07/2001 - 04/2000
4	Hereditary Sensory and Autonomic Neuropathies (HSAN) 10/2001 - 01/2000
3	Cardiovascular Diseases (Cardiovascular Disease) 11/2016 - 04/2000
3	Rheumatoid Arthritis 01/2011 - 05/2009
3	Silicosis 01/2011 - 10/2006
3	Glomerulonephritis 10/2010 - 05/2001
3	Stomach Neoplasms (Stomach Cancer) 01/2004 - 02/2001
3	Inborn Genetic Diseases (Disease, Hereditary) 10/2001 - 01/2000
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2001 - 03/2000
3	Leukemia 03/2001 - 08/2000
2	Reperfusion Injury 07/2013 - 06/2011
2	Hypertension (High Blood Pressure) 04/2012 - 01/2000
2	Vascular Diseases (Vascular Disease) 01/2012 - 07/2001
2	Nephritis 01/2011 - 05/2001
2	Malignant Mesothelioma 01/2011 - 10/2006
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2011 - 10/2010
2	Pancreatic Neoplasms (Pancreatic Cancer) 05/2009 - 08/2005
2	Multiple Myeloma 02/2008 - 12/2000
2	Glioma (Gliomas) 10/2007 - 04/2001
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2006 - 04/2001
2	Bronchiolitis Obliterans Syndrome 01/2005 - 06/2004
2	Starvation 11/2004 - 11/2000
2	Peptic Ulcer (Peptic Ulcers) 01/2004 - 07/2002
2	Infections 01/2004 - 08/2001
2	Lymphoma (Lymphomas) 10/2003 - 07/2000
2	Body Weight (Weight, Body) 09/2003 - 05/2001
2	Hyponatremia 04/2002 - 04/2002
2	Uniparental Disomy 10/2001 - 09/2000
2	Disseminated Intravascular Coagulation 07/2001 - 07/2000
2	Proteinuria 05/2001 - 05/2001
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2001 - 06/2000
2	Hypohidrosis 02/2001 - 01/2000
2	Parkinson Disease (Parkinson's Disease) 02/2001 - 01/2000
2	Atherosclerosis 01/2001 - 04/2000
2	Hemorrhage 01/2001 - 03/2000
2	Renal Insufficiency (Renal Failure) 07/2000 - 01/2000
2	Pheochromocytoma 05/2000 - 01/2000
1	Colorectal Neoplasms (Colorectal Cancer) 12/2022
1	Microsatellite Instability 01/2022
1	Brain Neoplasms (Brain Tumor) 01/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2015

Drug/Important Bio-Agent (IBA)

9	Peptides (Polypeptides)IBA 08/2014 - 01/2000
8	Proteins (Proteins, Gene)FDA Link 08/2014 - 06/2000
8	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2008 - 07/2000
7	TeaIBA 01/2004 - 01/2000
5	Messenger RNA (mRNA)IBA 06/2011 - 11/2000
5	AsbestosIBA 01/2011 - 05/2005
4	CytokinesIBA 05/2015 - 07/2001
4	3-(2-carboxyindol-3-yl)propionic acidIBA 10/2001 - 01/2000
4	Nerve Growth Factor (NGF)IBA 05/2001 - 01/2000
3	MicellesIBA 01/2017 - 01/2012
3	Phosphotransferases (Kinase)IBA 07/2013 - 06/2000
3	Silicon Dioxide (Silica)FDA LinkGeneric 01/2011 - 10/2006
3	AntigensIBA 01/2005 - 08/2001
3	InterferonsIBA 10/2003 - 07/2000
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2022 - 07/2000
2	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 05/2015 - 12/2000
2	CreatinineIBA 06/2011 - 01/2000
2	MineralsIBA 01/2011 - 10/2006
2	LigandsIBA 05/2009 - 10/2007
2	Therapeutic UsesIBA 05/2009 - 07/2001
2	Interferon-alpha (Interferon Alfa)IBA 08/2005 - 12/2000
2	Vasopressins (Vasopressin)IBA 02/2004 - 04/2002
2	Arginine Vasopressin (Argipressin)IBA 04/2002 - 12/2000
2	ZincIBA 04/2002 - 04/2002
2	Prednisolone (Predate)FDA LinkGeneric 09/2001 - 01/2000
2	Dacarbazine (DIC)FDA LinkGeneric 07/2001 - 07/2000
2	ResveratrolIBA 06/2001 - 05/2001
2	phenethylamineIBA 02/2001 - 01/2000
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2001 - 09/2000
2	Xanthine OxidaseIBA 01/2001 - 04/2000
1	Circulating Tumor DNAIBA 12/2022
1	Biomarkers (Surrogate Marker)IBA 12/2022
1	Bevacizumab (Avastin)FDA Link 12/2022
1	XELOXIBA 12/2022
1	Protein Isoforms (Isoforms)IBA 12/2022
1	B7-H1 AntigenIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	NivolumabIBA 01/2022
1	Phenobarbital (Luminal)FDA Link 01/2017
1	cyclic arginine-glycine-aspartic acid peptideIBA 01/2017
1	Epirubicin (Ellence)FDA LinkGeneric 01/2017
1	SodiumIBA 11/2016
1	SaltsIBA 11/2016
1	Gefitinib (Iressa)FDA Link 09/2015
1	PlatinumIBA 09/2015

Therapy/Procedure

13	Therapeutics 01/2017 - 01/2000
6	Transplantation 12/2010 - 07/2000
4	Stem Cell Transplantation 02/2008 - 08/2001
3	Stents 01/2015 - 01/2001
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2005 - 10/2003
3	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 10/2003 - 06/2000
2	Drug Therapy (Chemotherapy) 12/2022 - 09/2015
2	Intravenous Injections 05/2001 - 05/2001
2	Liver Transplantation 11/2000 - 11/2000
2	Aftercare (After-Treatment) 07/2000 - 03/2000
1	Combination Drug Therapy (Combination Chemotherapy) 09/2015